Table 2 Enriched and potentially deleterious variants in samples from Wales

From: Regionally enriched rare deleterious exonic variants in the UK and Ireland

ClinVar Variant Allele ID

Gene

Condition

Region

MAFREG

Enrichment (vs MAFNFE)

MAFAVE

HOMALT range

20826

SLC7A9

Cystinuria

Wales S

0.0039

44x

0.00048

[4,37]

133510

CHEK2

Hereditary cancer-predisposing syndrome

Wales N

Wales S

0.0051

0.0026

43x

22x

0.00051

[2,18]

[3,16]

71108

NPHS1

Finnish congenital nephrotic syndrome

Wales S

0.0025

42x

0.00031

[2,15]

16142

AGL

Glycogen Storage Disease Type III

Wales S

0.0009

32x

0.00015

[0,2]

815895

SMARCAL1

Schimke immuno-osseous dysplasia

Wales S

0.0012

28x

0.00015

[0,3]

203537

GAMT

Deficiency of guanidinoacetate methyltransferase

Wales S

0.0017

19x

0.00029

[1,7]

27983

SPR

Dystonia

Wales S

0.0019

16x

0.00025

[1,9]

105746

CEP290

Leber congenital amaurosis

Wales S

0.0014

14x

0.00029

[1,5]

414917

MME

Charcot-Marie-Tooth disease, axonal, type 2 T

Wales S

0.0015

5.2x

0.00044

[2,5]

  1. MAFREG: regional MAF of the variant.
  2. MAFNFE: MAF of the variant in Non-Finnish European individuals in gnomAD.
  3. MAFAVE: average MAF of the variant in the dataset of 10,001 unrelated individuals from 20 UK and Ireland regions.
  4. HOMALT range: predicted range of the regional number of individuals homozygous for the variant.